Fort Wayne, Ind.-based orthopedic implant company BioPoly has secured FDA approval for its new knee implant, according to an April 23 report from CBS affiliate WANE.
With the approval, the company can begin clinical trials for the device, which aims to address cartilage problems in patients with ongoing knee pain.
BioPoly has started seeking patients for the study, which is open to around 152 patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.